Ignacio, R. A. B., Chew, K. W., Moser, C., Currier, J. S., Eron, J. J., Javan, A. C., . . . Wohl, D. A. Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies. Elsevier.
Chicago Style (17th ed.) CitationIgnacio, Rachel A. Bender, et al. Tixagevimab/cilgavimab or Placebo for COVID-19 in ACTIV-2: Safety, Pharmacokinetics and Neutralizing and Anti-drug Antibodies. Elsevier.
MLA (9th ed.) CitationIgnacio, Rachel A. Bender, et al. Tixagevimab/cilgavimab or Placebo for COVID-19 in ACTIV-2: Safety, Pharmacokinetics and Neutralizing and Anti-drug Antibodies. Elsevier.
Warning: These citations may not always be 100% accurate.